Skip to content

Clinical trials

Phase 2/3 Major Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2/3 Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20081
20113
20133
20141
20152
20161
20171
20191
20211
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated6
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Magnus Medical2
New York State Psychiatric Institute2
Bo Hu1
Duke University1
Eli Lilly and Company1
Euthymics BioScience, Inc.1
Laureate Institute for Brain Research, Inc.1
Marta Peciña, MD PhD1
Massachusetts General Hospital1
Medical University of South Carolina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder22
Depressive Disorder4
Cardiovascular Diseases2
Mood Disorders2
Psychotic Disorders2
Alzheimer Disease1
Anorexia1
Bipolar Disorder1
Cognitive Dysfunction1
Depressive Disorder, Treatment-Resistant1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.